|
Insider Trading: PROVECTUS PHARMACEUTICALS INC
Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of PROVECTUS PHARMACEUTICALS INC in the last 24 months are illustrated in figures 1 and 2. Table 1 shows the monthly insider trading data of PROVECTUS PHARMACEUTICALS INC since year 2005. Table 2 shows the detailed insider transactions of PROVECTUS PHARMACEUTICALS INC since 2005.
The reporting company's ticker symbol is PVCT.
The reporting company's CIK number is 315545.
The total value of stock buying since 2005 is $974,328.
The total value of stock sales is $398,870.
The total value of stock exercises is $881,747.
1 year stock price chart,
1 day stock price chart
opopp opopopop
Figure 1. Monthly insider transaction values at PROVECTUS PHARMACEUTICALS INC (PVCT) in the past 24 months.
The trade values of insider stock buys, sales, and option exercises are in logarithmic scale
as shown on the right axis labels.
The detailed monthly and daily insider transactions are listed in the 2 tables below.
08 09 10 11 12 01 2007 02 03 04 05 06 07 08 09 10 11 12 01 2008 02 03 04 05 06 07 -
Figure 2. Average prices of insider buys, sales, and option exercises at PROVECTUS PHARMACEUTICALS INC (PVCT) in the past 24 months. See table 2 for insider transaction details.
08 09 10 11 12 01 2007 02 03 04 05 06 07 08 09 10 11 12 01 2008 02 03 04 05 06 07 -
Table 1. Monthly summaries of insider stock purchases, sales, and option exercises
for PROVECTUS PHARMACEUTICALS INC (PVCT).
Trading Period
year-month |
Insider Buying
Shares Value ($) |
Insider Sales
Shares Value ($) |
Option Exercises
Shares Value ($) |
| 2008-06 | 0 | 0 | 0 | 0 | 74,795 | 79,874 |
| 2008-05 | 0 | 0 | 0 | 0 | 63,281 | 39,867 |
| 2008-04 | 0 | 0 | 0 | 0 | 100,000 | 46,000 |
| 2007-12 | 0 | 0 | 0 | 0 | 330,881 | 309,373 |
| 2007-11 | 0 | 0 | 0 | 0 | 50,000 | 32,000 |
| 2007-09 | 0 | 0 | 120,000 | 318,560 | 34,375 | 19,000 |
| 2007-08 | 0 | 0 | 0 | 0 | 84,375 | 51,000 |
| 2007-07 | 0 | 0 | 0 | 0 | 6,250 | 2,000 |
| 2007-04 | 0 | 0 | 4,630 | 6,793 | 0 | 0 |
| 2007-03 | 0 | 0 | 10,000 | 11,940 | 9,375 | 3,000 |
| 2007-02 | 0 | 0 | 20,772 | 23,507 | 120,920 | 133,012 |
| 2007-01 | 679,048 | 713,000 | 17,500 | 21,120 | 0 | 0 |
| 2006-11 | 0 | 0 | 0 | 0 | 3,500 | 3,850 |
| 2006-10 | 0 | 0 | 0 | 0 | 3,500 | 3,850 |
| 2006-09 | 0 | 0 | 0 | 0 | 3,500 | 3,850 |
| 2006-08 | 0 | 0 | 15,000 | 16,950 | 6,625 | 4,850 |
| 2006-07 | 0 | 0 | 0 | 0 | 7,000 | 7,700 |
| 2006-06 | 0 | 0 | 0 | 0 | 6,250 | 2,000 |
| 2006-05 | 40,000 | 62,800 | 0 | 0 | 6,625 | 4,850 |
| 2006-04 | 0 | 0 | 0 | 0 | 6,791 | 5,032 |
| 2006-03 | 0 | 0 | 0 | 0 | 26,064 | 28,669 |
| 2006-02 | 0 | 0 | 0 | 0 | 3,734 | 4,107 |
| 2006-01 | 0 | 0 | 0 | 0 | 85,181 | 93,697 |
| 2005-12 | 264,705 | 198,528 | 0 | 0 | 3,788 | 4,166 |
Table 2. Detailed insider stock purchases, sales, and option exercises
for PROVECTUS PHARMACEUTICALS INC (PVCT)
| Trade Date |
Insider Name |
Trade Type |
Shares |
Price ($) |
Value ($) |
| 2008-06-24 | Wachter Eric Phd (Executive VP Pharmaceuticals) | Option Exercise | 30,000 | 1.02 | 30,600 |
| 2008-06-12 | Culpepper Peter R (Chief Financial Officer) | Option Exercise | 44,795 | 1.10 | 49,274 |
| 2008-05-30 | Wachter Eric Phd (Executive VP Pharmaceuticals) | Option Exercise | 63,281 | .63 | 39,867 |
| 2008-04-09 | Wachter Eric Phd (Vice President Pharmaceuticals) | Option Exercise | 100,000 | .46 | 46,000 |
| 2007-12-27 | Wachter Eric Phd (Vice President Pharmaceuticals) | Option Exercise | 330,881 | .94 | 309,373 |
| 2007-11-12 | Culpepper Peter R (Chief Financial Officer) | Option Exercise | 50,000 | .64 | 32,000 |
| 2007-09-22 | Adams Donald E (10% Owner) | Sale | 5,000 | 2.98 | 14,900 |
| 2007-09-13 | Culpepper Peter R (Chief Financial Officer) | Option Exercise | 25,000 | .64 | 16,000 |
| 2007-09-13 | Dees H Craig (Chief Executive Officer) | Option Exercise | 9,375 | .32 | 3,000 |
| 2007-09-06 | Adams Donald E (10% Owner) | Sale | 70,000 | 2.89 | 202,160 |
| 2007-09-05 | Adams Donald E (10% Owner) | Sale | 25,000 | 2.40 | 60,000 |
| 2007-09-04 | Adams Donald E (10% Owner) | Sale | 20,000 | 2.08 | 41,500 |
| 2007-08-23 | Culpepper Peter R (Chief Financial Officer) | Option Exercise | 75,000 | .64 | 48,000 |
| 2007-08-23 | Dees H Craig (Chief Executive Officer) | Option Exercise | 9,375 | .32 | 3,000 |
| 2007-07-02 | Dees H Craig (Chief Executive Officer) | Option Exercise | 6,250 | .32 | 2,000 |
| 2007-04-11 | Adams Donald E (10% Owner) | Sale | 630 | 1.45 | 913 |
| 2007-04-03 | Adams Donald E (10% Owner) | Sale | 4,000 | 1.47 | 5,880 |
| 2007-03-21 | Adams Donald E (10% Owner) | Sale | 2,000 | 1.29 | 2,580 |
| 2007-03-19 | Adams Donald E (10% Owner) | Sale | 2,000 | 1.24 | 2,480 |
| 2007-03-09 | Dees H Craig (Chief Executive Officer) | Option Exercise | 9,375 | .32 | 3,000 |
| 2007-03-07 | Adams Donald E (10% Owner) | Sale | 4,000 | 1.15 | 4,600 |
| 2007-03-02 | Adams Donald E (10% Owner) | Sale | 2,000 | 1.14 | 2,280 |
| 2007-02-23 | Adams Donald E (10% Owner) | Sale | 2,000 | 1.14 | 2,280 |
| 2007-02-20 | Adams Donald E (10% Owner) | Sale | 2,000 | 1.13 | 2,260 |
| 2007-02-15 | Wachter Eric Phd (Vice President Pharmaceuticals) | Option Exercise | 120,920 | 1.10 | 133,012 |
| 2007-02-13 | Adams Donald E (10% Owner) | Sale | 8,000 | 1.12 | 8,960 |
| 2007-02-07 | Adams Donald E (10% Owner) | Sale | 4,772 | 1.15 | 5,487 |
| 2007-02-06 | Adams Donald E (10% Owner) | Sale | 4,000 | 1.13 | 4,520 |
| 2007-01-31 | Adams Donald E (10% Owner) | Sale | 2,000 | 1.17 | 2,340 |
| 2007-01-27 | Adams Donald E (10% Owner) | Purchase | 679,048 | 1.05 | 713,000 |
| 2007-01-24 | Adams Donald E (10% Owner) | Sale | 1,500 | 1.20 | 1,800 |
| 2007-01-22 | Adams Donald E (10% Owner) | Sale | 6,000 | 1.20 | 7,200 |
| 2007-01-17 | Adams Donald E (10% Owner) | Sale | 2,000 | 1.23 | 2,460 |
| 2007-01-16 | Adams Donald E (10% Owner) | Sale | 6,000 | 1.22 | 7,320 |
| 2006-11-30 | Culpepper Peter R (Chief Financial Officer) | Option Exercise | 3,500 | 1.10 | 3,850 |
| 2006-10-30 | Culpepper Peter R (Chief Financial Officer) | Option Exercise | 3,500 | 1.10 | 3,850 |
| 2006-09-28 | Culpepper Peter R (Chief Financial Officer) | Option Exercise | 3,500 | 1.10 | 3,850 |
| 2006-08-30 | Culpepper Peter R (Chief Financial Officer) | Option Exercise | 3,500 | 1.10 | 3,850 |
| 2006-08-11 | Adams Donald E (10% Owner) | Sale | 15,000 | 1.13 | 16,950 |
| 2006-08-01 | Dees H Craig (Chief Executive Officer) | Option Exercise | 3,125 | .32 | 1,000 |
| 2006-07-30 | Culpepper Peter R (Chief Financial Officer) | Option Exercise | 3,500 | 1.10 | 3,850 |
| 2006-07-05 | Culpepper Peter R (Chief Financial Officer) | Option Exercise | 3,500 | 1.10 | 3,850 |
| 2006-06-05 | Dees H Craig (Chief Executive Officer) | Option Exercise | 6,250 | .32 | 2,000 |
| 2006-05-30 | Culpepper Peter R (Chief Financial Officer) | Option Exercise | 3,500 | 1.10 | 3,850 |
| 2006-05-30 | Dees H Craig (Chief Executive Officer) | Option Exercise | 3,125 | .32 | 1,000 |
| 2006-05-24 | Adams Donald E (10% Owner) | Purchase | 40,000 | 1.57 | 62,800 |
| 2006-04-30 | Culpepper Peter R (Chief Financial Officer) | Option Exercise | 3,666 | 1.10 | 4,032 |
| 2006-04-21 | Dees H Craig (Chief Executive Officer) | Option Exercise | 3,125 | .32 | 1,000 |
| 2006-03-31 | Culpepper Peter R (Chief Financial Officer) | Option Exercise | 3,666 | 1.10 | 4,032 |
| 2006-03-31 | Wachter Eric Phd (Vice President Pharmaceuticals) | Option Exercise | 22,398 | 1.10 | 24,637 |
| 2006-02-28 | Culpepper Peter R (Chief Financial Officer) | Option Exercise | 3,734 | 1.10 | 4,107 |
| 2006-01-31 | Culpepper Peter R (Chief Financial Officer) | Option Exercise | 3,499 | 1.10 | 3,848 |
| 2006-01-31 | Wachter Eric Phd (Vice President Pharm) | Option Exercise | 39,703 | 1.10 | 43,673 |
| 2006-01-04 | Wachter Eric Phd (Vice President Pharm) | Option Exercise | 41,979 | 1.10 | 46,176 |
| 2005-12-31 | Culpepper Peter R (Chief Financial Officer) | Option Exercise | 3,788 | 1.10 | 4,166 |
| 2005-12-09 | Wachter Eric Phd (Vice President Pharm) | Purchase | 264,705 | .75 | 198,528 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above tables cannot be completely guaranteed as to their accuracy.
For more insider trading information of PROVECTUS PHARMACEUTICALS INC (symbol PVCT,
CIK number 315545) see
the Securities and Exchange Commission (SEC) website.
|
|
